Abbott Laboratories (NYSE: ABT)
You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Abbott Laboratories Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
Abbott Laboratories Company Info
Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
News & Analysis
Dividend Kings of 2023
Get a list of current -- and potential future -- Dividend Kings and learn how to leverage these strong companies to build wealth.
Abbott Laboratories May Soon Launch a Game-Changing New Device in the U.S.
Abbott Laboratories is getting into the consumer wearables market.
3 Reasons to Buy Abbott Laboratories Stock
Don't just focus on the recent past.
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation
These companies are helping change medicine; they could make boatloads of money along the way.
Abbott Stock: Bear vs. Bull
Abbott is a favorite of income-oriented investors, but is the price right?
2 Dividend Kings to Buy on the Dip and Hold Forever
Don't ignore these stocks just because the rest of the market is.
Could Abbott Laboratories Stock Help You Become a Millionaire?
One promising area of its business is diabetes care, which experienced significant growth this year.
Is Abbott Laboratories a Buy?
If you're willing to invest with the right mindset, it could be a great option.
Valuation
Earnings Transcripts
Abbott Laboratories (ABT) Q3 2023 Earnings Call Transcript
ABT earnings call for the period ending September 30, 2023.
Abbott Laboratories (ABT) Q2 2023 Earnings Call Transcript
ABT earnings call for the period ending June 30, 2023.
Abbott Laboratories (ABT) Q4 2022 Earnings Call Transcript
ABT earnings call for the period ending December 31, 2022.
Abbott Laboratories (ABT) Q3 2022 Earnings Call Transcript
ABT earnings call for the period ending September 30, 2022.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.